Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

COMPLETED NA

Flourish HEC to Prevent Recurrence of BV

NCT05386147 · View on ClinicalTrials.gov ↗

Study Summary

In a population of women with heightened vulvovaginal sensitivity and recurrent bacterial vaginosis (BV), the use of the Flourish HEC Vaginal Care System is being tested for prevention of BV recurrence over six months of use.

Conditions Studied

Interventions

  • DEVICE Flourish HEC Vaginal Care System (contains a class II medical device plus other unregulated components)

Study Locations (1)

Pennsylvania

  • Center for Pelvic Medicine — Rosemont

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2021-12-22
Est. Completion 2022-11-15
Phase NA

Sponsor

Vaginal Biome Science

1 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05386147

The ClinicalTrials.gov registry entry for NCT05386147 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vaginal Biome Science, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 1 condition, with Bacterial Vaginosis appearing as the primary indexed condition, and to 1 intervention — of which Flourish HEC Vaginal Care System (contains a class II medical device plus other unregulated components) is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT05386147 reports 1 study location spanning 1 distinct geographic area — top geographies include Pennsylvania. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT05386147 about?

NCT05386147 is a clinical study titled "Flourish HEC to Prevent Recurrence of BV". In a population of women with heightened vulvovaginal sensitivity and recurrent bacterial vaginosis (BV), the use of the Flourish HEC Vaginal Care System is being tested for prevention of BV recurrence over six months of use.

What is the current status of trial NCT05386147?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2021-12-22. Estimated completion is 2022-11-15.

What conditions does trial NCT05386147 study?

This clinical trial studies the following conditions: Bacterial Vaginosis. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT05386147?

The interventions under investigation include: Flourish HEC Vaginal Care System (contains a class II medical device plus other unregulated components) (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT05386147?

This trial is sponsored by Vaginal Biome Science, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT05386147 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial